We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer Agrees to Pay $345 Million to Settle EpiPen Lawsuit
Pfizer Agrees to Pay $345 Million to Settle EpiPen Lawsuit
Pfizer has agreed to a $345 million settlement of a class action antitrust suit over the EpiPen, an epinephrine auto-injector used in the emergency treatment of anaphylaxis.
To View This Article:
Login
Subscribe To International Devices & Diagnostics Monitor